122 related articles for article (PubMed ID: 12192538)
1. Suppression of in vivo tumorigenicity of rat hepatoma cell line KDH-8 cells by soluble TGF-beta receptor type II.
Zhao W; Kobayashi M; Ding W; Yuan L; Seth P; Cornain S; Wang J; Okada F; Hosokawa M
Cancer Immunol Immunother; 2002 Sep; 51(7):381-8. PubMed ID: 12192538
[TBL] [Abstract][Full Text] [Related]
2. Restoration of interleukin-2 production in tumor-bearing rats through reducing tumor-derived transforming growth factor beta by treatment with bleomycin.
Yuan L; Kuramitsu Y; Li Y; Kobayashi M; Hosokawa M
Cancer Immunol Immunother; 1995 Dec; 41(6):355-62. PubMed ID: 8635193
[TBL] [Abstract][Full Text] [Related]
3. An oncolytic adenovirus expressing soluble transforming growth factor-beta type II receptor for targeting breast cancer: in vitro evaluation.
Wang ZG; Zhao W; Ramachandra M; Seth P
Mol Cancer Ther; 2006 Feb; 5(2):367-73. PubMed ID: 16505111
[TBL] [Abstract][Full Text] [Related]
4. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
5. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.
Bandyopadhyay A; Zhu Y; Cibull ML; Bao L; Chen C; Sun L
Cancer Res; 1999 Oct; 59(19):5041-6. PubMed ID: 10519421
[TBL] [Abstract][Full Text] [Related]
6. Restoration of macrophage tumoricidal activity by bleomycin correlates with the decreased production of transforming growth factor beta in rats bearing KDH-8 hepatoma cells.
Yuan L; Kobayashi M; Kuramitsu Y; Li Y; Matsushita K; Hosokawa M
Cancer Immunol Immunother; 1997 Oct; 45(2):71-6. PubMed ID: 9390197
[TBL] [Abstract][Full Text] [Related]
7. Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells.
Doré JJ; Edens M; Garamszegi N; Leof EB
J Biol Chem; 1998 Nov; 273(48):31770-7. PubMed ID: 9822641
[TBL] [Abstract][Full Text] [Related]
8. Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300.
Mori N; Morishita M; Tsukazaki T; Giam CZ; Kumatori A; Tanaka Y; Yamamoto N
Blood; 2001 Apr; 97(7):2137-44. PubMed ID: 11264182
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture.
Yamamoto H; Ueno H; Ooshima A; Takeshita A
J Biol Chem; 1996 Jul; 271(27):16253-9. PubMed ID: 8663151
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line.
Okamoto M; Oyasu R
Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.
Hall FL; Benya PD; Padilla SR; Carbonaro-Hall D; Williams R; Buckley S; Warburton D
Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):303-10. PubMed ID: 8645222
[TBL] [Abstract][Full Text] [Related]
12. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.
Wang J; Sun L; Myeroff L; Wang X; Gentry LE; Yang J; Liang J; Zborowska E; Markowitz S; Willson JK
J Biol Chem; 1995 Sep; 270(37):22044-9. PubMed ID: 7665626
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
[TBL] [Abstract][Full Text] [Related]
15. Evidence for control of nitric oxide synthesis by intracellular transforming growth factor-beta1 in tumor cells. Implications for tumor development.
Lagadec P; Raynal S; Lieubeau B; Onier N; Arnould L; Saint-Giorgio V; Lawrence DA; Jeannin JF
Am J Pathol; 1999 Jun; 154(6):1867-76. PubMed ID: 10362813
[TBL] [Abstract][Full Text] [Related]
16. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line.
Yamamoto N; Imai J; Watanabe M; Hiroi N; Sugano S; Yoshino G
Horm Metab Res; 2006 Mar; 38(3):159-66. PubMed ID: 16673206
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis.
Siegel PM; Shu W; Cardiff RD; Muller WJ; Massagué J
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8430-5. PubMed ID: 12808151
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of a soluble transforming growth factor beta type II receptor on the activation of rat hepatic stellate cells in primary culture.
Cui X; Shimizu I; Lu G; Itonaga M; Inoue H; Shono M; Tamaki K; Fukuno H; Ueno H; Ito S
J Hepatol; 2003 Nov; 39(5):731-7. PubMed ID: 14568254
[TBL] [Abstract][Full Text] [Related]
19. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
[TBL] [Abstract][Full Text] [Related]
20. Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction.
Laiho M; Weis MB; Massagué J
J Biol Chem; 1990 Oct; 265(30):18518-24. PubMed ID: 2170414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
